T Hermiston
Overview
Explore the profile of T Hermiston including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
397
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beier R, Hermiston T, Mumberg D
Gene Ther
. 2012 Feb;
20(1):102-11.
PMID: 22357510
Newcastle disease virus (NDV) is an oncolytic paramyxovirus with a nonsegmented single-stranded RNA genome. In this report, a recombinant oncolytic NDV was passaged in human tumor xenografts and reisolated and...
2.
Bauzon M, Jin F, Kretschmer P, Hermiston T
Gene Ther
. 2009 May;
16(9):1169-74.
PMID: 19458647
We have generated a novel oncolytic Adenovirus (Ad), ColoAd1, with significantly increased potency ( approximately 100-fold) relative to its parent viruses, Ad11p and Ad3, or to the clinically tested oncolytic...
3.
Kuhn I, LARSEN B, Gross C, Hermiston T
Gene Ther
. 2006 Oct;
14(2):180-4.
PMID: 17024108
Accurate adenovirus (Ad) quantification requires labor- and time-intensive viral stock purification. While crude viral lysates can be titered by plaque assay, this cell-based assay is neither rapid nor accurate. Consequently,...
4.
Green N, Herbert C, Hale S, Hale A, Mautner V, Harkins R, et al.
Gene Ther
. 2004 Jun;
11(16):1256-63.
PMID: 15215884
Systemic delivery of adenoviral vectors is a major goal in cancer gene therapy, but is currently prohibited by rapid hepatic uptake of virus following intravenous injection with levels of viable...
5.
Hawkins L, Hermiston T
Gene Ther
. 2001 Aug;
8(15):1142-8.
PMID: 11509944
Successful therapies for cancer need to deal with the complexity associated with the human tumor. Studies of tumor and viral biology have progressed to a point where replicating viruses are...
6.
Shen Y, KITZES G, Nye J, Fattaey A, Hermiston T
J Virol
. 2001 Apr;
75(9):4297-307.
PMID: 11287579
The E1B-55K protein plays an important role during human adenovirus type 5 productive infection. In the early phase of the viral infection, E1B-55K binds to and inactivates the tumor suppressor...
7.
Heise C, Hermiston T, Johnson L, Brooks G, Sampson-Johannes A, Williams A, et al.
Nat Med
. 2000 Oct;
6(10):1134-9.
PMID: 11017145
Replication-selective oncolytic viruses constitute a rapidly evolving and new treatment platform for cancer. Gene-deleted viruses have been engineered for tumor selectivity, but these gene deletions also reduce the anti-cancer potency...
8.
9.
10.
Kirn D, Hermiston T, McCormick F
Nat Med
. 1998 Dec;
4(12):1341-2.
PMID: 9846551
No abstract available.